Cargando…
Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Despite the use of optimized first-line therapy, GBM is still associated with a poor prognosis and an effective second-line therapy remains an important challenge in this patient population. In 2009, the US Foo...
Autores principales: | Schweneker, Katrin, Clemm, Christoph, Brügel, Melanie, Souvatzoglou, Michael, Hermisson, Mirjam, Schmidt-Graf, Friederike, Zimmer, Claus, Peschel, Christian, Jost, Philipp J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423626/ https://www.ncbi.nlm.nih.gov/pubmed/25954595 http://dx.doi.org/10.1186/2162-3619-3-29 |
Ejemplares similares
-
Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis
por: Kram, Helena, et al.
Publicado: (2022) -
Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience
por: Straube, Christoph, et al.
Publicado: (2017) -
Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)
por: Straube, Christoph, et al.
Publicado: (2018) -
Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015) -
ACT-6 Clinical manifestations of the patients with relapsed glioblastoma after bevacizumab treatment
por: Kikuchi, Miyu, et al.
Publicado: (2021)